Related Experiment Video
Updated: Jun 9, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
Cardiovascular Disease Risk Estimation Using Blood Biomarkers and the QRISK3 Stratification Tool: A Cross-Sectional
Ahmed Salem1, Fanar Alsmarat1, Tasneem Al-Awaideh2
1Department of Anatomy, Physiology and Biochemistry, Faculty of Medicine The Hashemite University Zarqa Jordan.
A significant portion of Jordanians face elevated cardiovascular disease (CVD) risk, with smoking increasing this likelihood. Early screening and intervention are crucial for managing CVD risk in the population.
Area of Science:
- Cardiology
- Public Health
- Epidemiology
Background:
- Cardiovascular diseases (CVD) represent the primary cause of mortality in Jordan.
- Assessing 10-year CVD risk and associated biomarkers is vital for public health initiatives.
Purpose of the Study:
- To estimate the prevalence of 10-year CVD risk using the QRISK3 tool in a Jordanian sample.
- To evaluate fibrinogen levels and lipid profiles as supplementary CVD risk indicators.
Main Methods:
- A cross-sectional study was conducted in Amman, Jordan, involving 251 participants aged 25-64.
- Data collection included questionnaires and blood sample analysis for fibrinogen and lipid profiles.
- The study adhered to STROBE guidelines for observational research.
Main Results:
- 31.1% of participants had a QRISK3 score ≥10%, and 14.3% had a score >20%.
- Active smokers exhibited higher CVD risk scores and prevalence of atrial fibrillation.
- 77.7% had non-optimal lipid profiles, with longer-term smokers showing lower HDL levels.
Conclusions:
- A substantial proportion of the study sample faces elevated CVD risk, particularly smokers.
- Findings highlight the need for routine CVD risk screening in primary care for early intervention.
- Limitations include convenience sampling and small sample size, restricting generalizability to the entire Jordanian population.
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Relative Risk
Assessment of blood pressure in brachial artery(two-step method)
